US Stock MarketDetailed Quotes
CAPR Capricor Therapeutics
- 5.330
- -0.080-1.48%
Close Apr 29 16:00 ET
- 5.480
- +0.150+2.81%
Post 19:59 ET
167.91MMarket Cap-6421P/E (TTM)
5.682High5.270Low448.90KVolume5.650Open5.410Pre Close2.45MTurnover1.72%Turnover RatioLossP/E (Static)31.50MShares8.22152wk High7.43P/B139.03MFloat Cap2.68052wk Low--Dividend TTM26.08MShs Float7999.998Historical High--Div YieldTTM7.62%Amplitude0.880Historical Low5.454Avg Price1Lot Size
Capricor Therapeutics Key Stats
Quarterly+Annual
YOY
| (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | (Q1)Mar 31, 2023 | (FY)Dec 31, 2022 | (Q4)Dec 31, 2022 | (Q3)Sep 30, 2022 | (Q2)Jun 30, 2022 | (Q1)Mar 31, 2022 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -620.61%-25.6M | -67.98%-11.59M | -54.69%-8.79M | -43.95%-9.42M | -82.49%4.21M | 129.25%4.92M | -22.65%-6.9M | -70.33%-5.69M | -44.92%-6.54M | 822.26%24.05M |
| Net income from continuing operations | 23.20%-22.29M | 90.13%-762.09K | -0.31%-6.39M | -3.62%-7.37M | 0.64%-7.77M | -44.93%-29.02M | -24.72%-7.72M | -62.04%-6.37M | -49.73%-7.11M | -51.75%-7.82M |
| Operating gains losses | -82.37%6.04K | --653 | ---- | ---- | ---- | 333.47%34.27K | ---- | ---- | ---- | ---- |
| Depreciation and amortization | 100.49%1.07M | 60.55%307.61K | 101.76%276.47K | 127.39%254.7K | 148.78%230.1K | 116.99%533.13K | 143.63%191.6K | 111.72%137.03K | 114.60%112.01K | 84.47%92.49K |
| Other non cash items | -115.01%-24.28K | -59.06%-10.36K | -104.46%-1.02K | -108.87%-6.45K | -108.87%-6.45K | 234.21%161.74K | ---6.51K | --22.79K | --72.73K | --72.73K |
| Change In working capital | -140.88%-11.75M | -2,267.67%-12.99M | -684.10%-4.4M | -405.24%-3.92M | -68.79%9.56M | 10,803.32%28.75M | -55.81%-548.71K | -193.76%-561.44K | -264.93%-775.51K | 2,904.95%30.63M |
| -Change in receivables | -6,204.57%-9.82M | ---9.82M | --0 | --0 | --0 | 60.22%-155.83K | --0 | --0 | ---190.58K | --34.75K |
| -Change in prepaid assets | -131.61%-75.88K | 6.74%-537.36K | -60.26%125.42K | 2.56%291.26K | -79.33%44.8K | 261.40%240.05K | 34.60%-576.21K | -15.72%315.59K | 242.05%283.98K | -21.16%216.69K |
| -Change in payables and accrued expense | 9.78%1.33M | -154.86%-541.71K | 132.06%1.66M | 66.69%-291.92K | 31.14%501.82K | 21.89%1.21M | 35.73%987.41K | 485.47%714.54K | -196.57%-876.45K | -48.61%382.66K |
| -Change in other current assets | --0 | --0 | --0 | ---- | ---- | 104.04%7.55K | --0 | --0 | ---- | ---- |
| -Change in other working capital | -111.58%-3.18M | -117.53%-2.09M | -288.66%-6.19M | ---3.92M | -69.96%9.01M | --27.45M | ---959.9K | ---1.59M | --0 | --30M |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -620.61%-25.6M | -67.98%-11.59M | -54.69%-8.79M | -43.95%-9.42M | -82.49%4.21M | 129.25%4.92M | -22.65%-6.9M | -70.33%-5.69M | -44.92%-6.54M | 822.26%24.05M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 114.56%5.11M | -214.01%-5.86M | 284.87%7.72M | 118.25%6.46M | -413.58%-3.21M | -2,831.78%-35.07M | 1,494.77%5.14M | -791.98%-4.18M | -10,882.05%-35.41M | -1,594.19%-625.36K |
| Net PPE purchase and sale | 39.06%-2.05M | 40.35%-729.22K | 42.53%-631.75K | 43.42%-233.44K | 27.54%-453.12K | -180.85%-3.36M | -231.60%-1.22M | -134.77%-1.1M | -27.94%-412.56K | -1,594.19%-625.36K |
| Net investment purchase and sale | 122.56%7.16M | -180.66%-5.13M | 371.44%8.35M | 119.13%6.69M | ---2.76M | ---31.71M | --6.36M | ---3.08M | ---35M | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 114.56%5.11M | -214.01%-5.86M | 284.87%7.72M | 118.25%6.46M | -413.58%-3.21M | -2,831.78%-35.07M | 1,494.77%5.14M | -791.98%-4.18M | -10,882.05%-35.41M | -1,594.19%-625.36K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 424.84%25.58M | 685.45%23.17M | -88.25%221.08K | 14,481.33%2.19M | -85.82%3.9K | -75.90%4.87M | 6,861.35%2.95M | -71.35%1.88M | -98.55%15.01K | -99.78%27.47K |
| Net common stock issuance | 431.18%25.52M | 692.41%23.16M | -88.24%221.08K | ---- | ---- | -76.19%4.8M | 189,549.77%2.92M | -71.35%1.88M | ---- | ---- |
| Proceeds from stock option exercised by employees | -8.11%64.6K | -88.50%3.03K | --0 | 284.37%57.68K | -85.82%3.9K | 39.05%70.3K | -40.07%26.32K | -70.88%1.52K | --15.01K | 1,812.60%27.47K |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 424.84%25.58M | 685.45%23.17M | -88.25%221.08K | 14,481.33%2.19M | -85.82%3.9K | -75.90%4.87M | 6,861.35%2.95M | -71.35%1.88M | -98.55%15.01K | -99.78%27.47K |
| Net cash flow | ||||||||||
| Beginning cash position | -72.47%9.6M | 6.79%8.98M | -40.00%9.84M | -81.82%10.61M | -72.47%9.6M | 6.79%34.89M | -79.40%8.41M | -56.95%16.39M | 39.29%58.33M | 6.79%34.89M |
| Current changes in cash | 120.14%5.09M | 380.01%5.71M | 89.32%-852.47K | 98.17%-768.4K | -95.73%1M | -1,239.14%-25.28M | 119.98%1.19M | -389.02%-7.98M | -1,003.22%-41.94M | 154.50%23.45M |
| End cash Position | 53.02%14.69M | 53.02%14.69M | 6.79%8.98M | -40.00%9.84M | -81.82%10.61M | -72.47%9.6M | -72.47%9.6M | -79.40%8.41M | -56.95%16.39M | 39.29%58.33M |
| Free cash flow | -1,875.58%-27.64M | -51.68%-12.32M | -38.93%-9.43M | -38.77%-9.65M | -83.96%3.76M | 108.65%1.56M | -35.49%-8.12M | -78.26%-6.78M | -43.79%-6.95M | 795.76%23.42M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- |
Analysis
Price Target
No Data
Heat List
US
Overall
Symbol
Latest Price
%Chg